FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

KAISER RICHARD KAISER

2. Date of Event Requiring Statement (MM/DD/YYYY)
8/10/2018 

3. Issuer Name and Ticker or Trading Symbol

BIOFORCE NANOSCIENCES HOLDINGS, INC. [BFNH]

(Last)        (First)        (Middle)

3419 VIRGINIA BEACH BLVD, UNIT 252

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            ___ X ___ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Secretary/Acting CFO /

(Street)

VIRGINIA BEACH, VA 23452       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   10000000   (1) D    
Common Stock   190000   I   YES INTERNATIONAL   (1)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  In 2014, 10,000,000 shares of common stock were issued to Mr. Kaiser in connection with past services rendered to the Company. Mr. Kaiser owns directly 10,000,000 shares of common stock and he owns 190,000 shares beneficially through his Company, Yes International, Inc.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
KAISER RICHARD KAISER
3419 VIRGINIA BEACH BLVD, UNIT 252
VIRGINIA BEACH, VA 23452 		X X Secretary/Acting CFO

Signatures
/s/ Richard Kaiser 8/10/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Grafico Azioni BioForce Nanosciences (PK) (USOTC:BFNH)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di BioForce Nanosciences (PK)
Grafico Azioni BioForce Nanosciences (PK) (USOTC:BFNH)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di BioForce Nanosciences (PK)